Sunic D, Belford D A, McNeil J D, Wiebkin O W
Department of Medicine, University of Adelaide, South Australia.
Biochim Biophys Acta. 1995 Aug 17;1245(1):43-8. doi: 10.1016/0304-4165(95)00076-n.
Cultured chondrocytes respond to insulin-like growth factors (IGFs) by increasing the production of proteoglycans and insulin-like growth factor binding proteins (IGF-BPs). To investigate the biological effects of IGFs and IGF-BPs, isolated bovine articular and ovine growth-plate chondrocytes were cultured at high density in the presence of IGF-1, and its truncated form, des (1-3) IGF-I. Both growth factors stimulated the production of IGF-BPs in articular and growth-plate chondrocyte monolayers. Western ligand blots showed that bovine articular chondrocytes released two forms of IGF-BPs into conditioned medium with molecular weights of 29 and 31 kDa. Ovine growth-plate chondrocytes released four different forms of IGF-BPs of approx. 22, 24; 29-30 and 34 kDa. IGF-I and des (1-3) IGF-I stimulated total proteoglycan synthesis by articular chondrocytes up to 1.5-fold. The truncated analogue was more potent at lower concentrations, particularly in stimulating incorporation of newly synthesized proteoglycans into the cell-layer. The maximal stimulation of proteoglycan synthesis in ovine growth-plate chondrocyte culture was 3-fold with des (1-3) IGF-I, while IGF-I enhanced proteoglycan production by only 2-fold over the concentrations used. Our results suggest that endogenous IGF-BPs in chondrocyte cultures act as a part of a feed-back mechanism which diminishes the bioactivity of IGF-I.
培养的软骨细胞通过增加蛋白聚糖和胰岛素样生长因子结合蛋白(IGF-BPs)的产生来对胰岛素样生长因子(IGFs)作出反应。为了研究IGFs和IGF-BPs的生物学效应,将分离的牛关节软骨细胞和羊生长板软骨细胞在IGF-1及其截短形式des(1-3)IGF-I存在的情况下进行高密度培养。两种生长因子均刺激关节软骨细胞和生长板软骨细胞单层中IGF-BPs的产生。Western配体印迹显示,牛关节软骨细胞将两种形式的IGF-BPs释放到条件培养基中,分子量分别为29 kDa和31 kDa。羊生长板软骨细胞释放出四种不同形式的IGF-BPs,分子量约为22、24、29 - 30和34 kDa。IGF-I和des(1-3)IGF-I刺激关节软骨细胞的总蛋白聚糖合成增加至1.5倍。截短的类似物在较低浓度下更有效,特别是在刺激新合成的蛋白聚糖掺入细胞层方面。在羊生长板软骨细胞培养中,des(1-3)IGF-I对蛋白聚糖合成的最大刺激为3倍,而IGF-I在所使用的浓度范围内仅使蛋白聚糖产量提高2倍。我们的结果表明,软骨细胞培养物中的内源性IGF-BPs作为反馈机制的一部分,会降低IGF-I的生物活性。